| 1 |
Gawarammana IB, Buckley NA. Medical management of paraquat ingestion[J]. Br J Clin Pharmacol, 2011, 72 (5): 745-757,
|
| 2 |
Yin Y, Guo X, Zhang SL, et al. Analysis of paraquat intoxication epidemic (2002-2011) within China[J]. Biomed Environ Sci, 2013, 26 (6): 509-512,
|
| 3 |
Kervégant M, Merigot L, Glaizal M, et al. Paraquat poisonings in France during the European ban: experience of the poison control center in Marseille[J]. J Med Toxicol, 2013, 9 (2): 144-147.
|
| 4 |
Yamashita M, Yamashita M, Ando Y. A long-term follow-up of lung function in survivors of paraquat poisoning[J]. Hum Exp Toxicol, 2000, 19 (2): 99-103.
|
| 5 |
Peng J, Stevenson FF, Oo ML, et al. Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation[J]. Free Radic Biol Med, 2009, 46 (2): 312-320.
|
| 6 |
Morán JM, Ortiz-Ortiz MA, Ruiz-Mesa LM, et al. Nitric oxide in paraquat-mediated toxicity: a review[J]. J Biochem Mol Toxicol, 2010, 24 (6): 402-409.
|
| 7 |
Shang AD, Lu YQ. A case report of severe paraquat poisoning in an HIV-positive patient: an unexpected outcome and inspiration[J]. Medicine (Baltimore), 2015, 94 (8): e587.
|
| 8 |
Zhang Q, Wu WZ, Lu YQ, et al. Successful treatment of patients with paraquat intoxication: three case reports and review of the literature[J]. J Zhejiang Univ Sci B, 2012, 13 (5): 413-418.
|
| 9 |
Huang WD, Wang JZ, Lu YQ, et al. Lysine acetylsa-licylate ameliorates lung injury in rats acutely exposed to paraquat[J]. Chin Med J (Engl), 2011, 124 (16): 2496-2501.
|
| 10 |
Chen Y, Nie YC, Luo YL, et al. Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice[J]. Food Chem Toxicol, 2013 (58): 133-140.
|
| 11 |
Chen J, Zeng T, Zhao X, et al. Docosahexaenoic acid (DHA) ameliorates paraquat-induced pulmonary fibrosis in rats possibly through up-regulation of Smad 7 and SnoN[J]. Food Chem Toxicol, 2013 (57): 330-337.
|
| 12 |
Cho SC, Rhim JH, Choi HR, et al. Protective effect of 4,4'-diaminodiphenylsulfone against paraquat-induced mouse lung injury[J]. Exp Mol Med, 2011, 43 (9): 525-537,
|
| 13 |
Choi JS, Jou SS, Oh MH, et al. The dose of cyclophosphamide for treating paraquat-induced rat lung injury[J]. Korean J Intern Med, 2013, 28 (4): 420-427.
|
| 14 |
Bartis D, Mise N, Mahida RY, et al. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?[J]. Thorax, 2014, 69 (8): 760-765.
|
| 15 |
Yang T, Chen M, Sun T. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells[J]. Cell Physiol Biochem, 2013, 31 (6): 863-874.
|
| 16 |
Yasui M, Miyazaki Y, Mitaka K, et al. Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis[J]. J Med Dent Sci, 2012, 59 (1): 29-41.
|
| 17 |
Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis[J]. Annu Rev Physiol, 2011 (73): 413-435.
|
| 18 |
Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders[J]. Am J Pathol, 2011, 179 (3): 1074-1080.
|
| 19 |
Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers[J]. Proc Am Thorac Soc, 2012, 9 (3): 111-116.
|
| 20 |
Gharaee-Kermani M, Hu B, Phan SH, et al. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast[J]. Curr Med Chem, 2009, 16 (11): 1400-1417.
|
| 21 |
Goodwin A, Jenkins G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis[J]. Biochem Soc Trans, 2009, 37 (Pt 4): 849-854.
|
| 22 |
Deng YL, Xiong XZ, Cheng NS. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists[J]. Hepatobiliary Pancreat Dis Int, 2012, 11 (5): 467-478.
|
| 23 |
Kolosova I, Nethery D, Kern JA. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells[J]. J Cell Physiol, 2011, 226 (5): 1248-1254.
|
| 24 |
Strippoli R, Benedicto I, Perez Lozano ML, et al. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells[J]. PLoS One, 2012, 7 (2): e31492.
|